Skip to Main Content

Paper Details

Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland.
Nature Communications
12
2022
BNT162b2, COVID-19, CVST, ITP, hemorrhagic events, idiopathic thrombocytopenic purpura, thrombocytopenic, thrombocytopenic, thromboembolic and hemorrhagic events, thromboembolic
Author NameAffiliation
Igor RudanUsher Institute, The University of Edinburgh
  • 1 - 1

Datasets

Release 1.2